CPT® Code 80151

The CPT® Code 80151 refers to a laboratory test specifically designed to monitor therapeutic levels of amiodarone, a critical medication utilized in the management of life-threatening arrhythmias. Amiodarone is particularly effective for conditions such as ventricular fibrillation, unstable ventricular tachycardia, and atrial fibrillation, especially in patients who have shown minimal or no response to other antiarrhythmic agents. One of the notable characteristics of amiodarone is its long half-life, which results in a prolonged elimination period from the body, averaging around 53 days. This extended duration necessitates careful monitoring to ensure that therapeutic levels are maintained and to avoid potential toxicity. The metabolism of amiodarone occurs primarily in the liver and intestines, where it is converted into its active metabolite, N-desethylamiodarone (DEA). This metabolite retains similar activity and serum concentrations as the parent drug, complicating the monitoring process. Clinicians must be aware of the adverse effects associated with amiodarone, which can include thyroid dysfunction, as well as neurological, hepatic, and gastrointestinal toxicity. For effective monitoring, the therapeutic concentration trough level of amiodarone is established between 0.5 to 2.0 mcg/mL, with levels exceeding 2.5 mcg/mL considered toxic. To obtain accurate measurements, a blood specimen is collected prior to dosing to ensure a trough draw at steady state concentration. Following collection, plasma or serum must be separated from cellular components within two hours and placed in an appropriate tube for analysis. The quantitative assessment of amiodarone levels is performed using liquid chromatography-tandem mass spectrometry, which provides precise values for the concentration of the drug. While the assay also reports the concentration of its active metabolite, it is important to note that no established therapeutic range exists for DEA, although its levels are generally comparable to those of the parent drug.